Skip to content

Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy

Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy: The GENETIC Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04513054
Acronym
GENETIC
Enrollment
700
Registered
2020-08-14
Start date
2019-03-12
Completion date
2028-12-31
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo Cardiomyopathy

Brief summary

Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.

Detailed description

Acute stress-induced (takotsubo) cardiomyopathy presents like a myocardial infarct, is triggered by intense emotional or physical stress, and can have catastrophic and potentially fatal consequences. Despite data linking takotsubo cardiomyopathy with conditions that have a recognized genetic predisposition (such as mental health and neurological problems), a systematic and comprehensive characterisation of the genetic-epidemiologic factors in takotsubo is lacking. The researchers propose to further investigate this disorder by collecting blood from probands and characterising the genotype of patients with takotsubo cardiomyopathy in a large scale, nationwide genome wide association study. The investigators will also archive DNA for identification of future candidate genetic variants. Ultimately, understanding the underlying predisposition of this poorly understood neuro-psycho-cardiac disorder is essential if we are to move this field forward.

Interventions

Blood collection for genetic analysis

Sponsors

University of Aberdeen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Single group observational study.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date. * Familial cases elsewhere in the world who would be willing to participate.

Exclusion criteria

* Unwillingness to participate

Design outcomes

Primary

MeasureTime frameDescription
Genome Wide Association StudyAt baselineGenome Wide Association Study to search for susceptibility variants

Countries

United Kingdom

Contacts

CONTACTAmelia E Rudd, MSc
a.e.rudd@abdn.ac.uk01224559473
PRINCIPAL_INVESTIGATORDana K Dawson, MD, MPhil

University of Aberdeen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026